Thomas Engber
Corporate Officer/Principal presso Disarm Therapeutics, Inc.
Provenienza dei contatti di primo grado di Thomas Engber
Entità | Tipo di entità | Settore Industriale | |
---|---|---|---|
Disarm Therapeutics, Inc.
Disarm Therapeutics, Inc. BiotechnologyHealth Technology Disarm Therapeutics, Inc. engages in the development of therapeutics to treat patients with neurological diseases. It includes multiple sclerosis, amyotrophic lateral sclerosis, glaucoma, and peripheral neuropathies. The company was founded by Jason Rhodes, Jeffrey Milbrandt, Raul Krauss, Aaron DiAntonio, and Rajesh Devraj on October 21, 2016 and is headquartered in Cambridge, MA.
8
| Subsidiary | Biotechnology | 8 |
Grafico delle società connesse in secondo grado
Relazione in diverse aziende
Società connesse a Thomas Engber tramite i suoi contatti personali
Società | Settore | Persone collegate | Posizione principale |
---|---|---|---|
PFIZER, INC. | Pharmaceuticals: Major | Director/Board Member | |
ASTRAZENECA PLC | Pharmaceuticals: Major | Director/Board Member | |
GENERAL AMERICAN INVESTORS COMPANY, INC. | Investment Trusts/Mutual Funds | Corporate Officer/Principal | |
NEUROCRINE BIOSCIENCES, INC. | Pharmaceuticals: Major | Director/Board Member | |
BIOGEN INC. | Pharmaceuticals: Major | Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Medical Specialties | Sales & Marketing | |
PORTOLA PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member | |
ZELTIQ AESTHETICS INC | Medical Specialties | Chairman | |
Euclises Pharmaceuticals, Inc.
Euclises Pharmaceuticals, Inc. Hospital/Nursing ManagementHealth Services Euclises Pharmaceuticals, Inc. operates as a biopharmaceutical company. The firm develops a portfolio of COX-2 inhibitors optimized for cancer treatment based on its proprietary Euclicoxib platform and is in the process of selecting a lead clinical development candidate. The company was founded by John J. Talley in 2011 and is headquartered in St. Louis, MO. | Hospital/Nursing Management | Director/Board Member | |
Harvard University
Harvard University Other Consumer ServicesConsumer Services Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA. | College/University | Doctorate Degree Doctorate Degree | |
Stanford University | College/University | Undergraduate Degree | |
Boston University | College/University | Masters Business Admin | |
Takeda America Holdings, Inc.
Takeda America Holdings, Inc. Financial ConglomeratesFinance Takeda America Holdings, Inc. is a wholly owned subsidary of Takeda Pharmaceutical Co. Ltd.. It handles cash management & investment activities of the Takeda within the North America Region. The company was founded in 1993 and is headquartered in New York, NY. | Financial Conglomerates | Private Equity Investor | |
Atlas Venture Advisors, Inc.
Atlas Venture Advisors, Inc. Investment ManagersFinance Atlas Venture Advisors Inc (Atlas Venture Advisors) is a venture capital firm founded in 1980 by Christopher Julian Spray. The firm is headquartered in Cambridge, Massachusetts. | Investment Managers | Private Equity Investor Consultant / Advisor Consultant / Advisor | |
Cyberkinetics Neurotechnology Systems, Inc.
Cyberkinetics Neurotechnology Systems, Inc. Medical SpecialtiesHealth Technology Cyberkinetics Neurotechnology Systems, Inc. manufactures medical devices. The company was founded by John Donoghue on February 6, 2002 and is headquartered in Foxborough, MA. | Medical Specialties | Director of Finance/CFO | |
Duquesne University of The Holy Spirit | College/University | Doctorate Degree | |
Miami University | College/University | Graduate Degree | |
Western Illinois University | College/University | Undergraduate Degree | |
Hydra Biosciences, Inc.
Hydra Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Hydra Biosciences, Inc. develops pharmaceutical products. It is focused in major therapeutic areas, which include pain, inflammation, renal, anxiety, and pulmonary diseases. The company was founded by Laurie Bartlett Keating, Dean Y. Li, David E. Clapham, and Mark T. Keating in 2001 and is headquartered in Belmont, MA. | Pharmaceuticals: Major | Director/Board Member | |
Apple Tree venture Managemnet Llc//vc
Apple Tree venture Managemnet Llc//vc Investment ManagersFinance Apple Tree venture Managemnet LLC (Apple Tree Partners) is a venture capital firm founded by Seth Harrison in 1999. The firm is headquartered in New York with an additional offices in London, San Francisco and Cambridge. | Investment Managers | Consultant / Advisor | |
Biogen Idec, Inc. (North Carolina)
Biogen Idec, Inc. (North Carolina) Pharmaceuticals: MajorHealth Technology Part of Biogen, Inc., Biogen Idec, Inc. (North Carolina) is a pharmaceutical company based in Durham, NC. The company develops pharmaceutical products. Michel Pericles Vounatsos has been the CEO of the company since 2016. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
American Academy of Neurology
American Academy of Neurology Miscellaneous Commercial ServicesCommercial Services American Academy of Neurology operates a professional society which represents neurologists and neuroscientists. The company was founded in 1948 and is headquartered in Minneapolis, MN. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
Linden Bioscience
Linden Bioscience Pharmaceuticals: MajorHealth Technology Part of Linden Technologies, Inc., Linden Bioscience is a company that develops pharmaceuticals. The company is based in Woburn, MA. | Pharmaceuticals: Major | Corporate Officer/Principal | |
PA Consulting Group, Inc.
PA Consulting Group, Inc. Miscellaneous Commercial ServicesCommercial Services PA Consulting Group, Inc. provides management consulting services. The company is headquartered in New York, NY. | Miscellaneous Commercial Services | Consultant / Advisor | |
Harvard Medical School | College/University | Corporate Officer/Principal | |
Jubilant Biosys Ltd.
Jubilant Biosys Ltd. BiotechnologyHealth Technology Jubilant Biosys Ltd. specializes in drug discovery services, proprietary in-house innovation, and strategic investments. Its services include discovery informatics, computational chemistry, structural biology, chemistry, in vitro and in vivo biology, and toxicology. The company was founded by VN Balaji in 2001 and is headquartered in Noida, India. | Biotechnology | Private Equity Investor | |
Longwood Fund Management LLC
Longwood Fund Management LLC Investment ManagersFinance Longwood Fund Management LLC (Longwood Fund) is a venture capital firm founded in 2010 by Christoph H. Westphal, Michelle Detwiler and Richard H. Aldrich. The firm is headquartered in Boston, Massachusetts. | Investment Managers | Consultant / Advisor | |
AlphaGene, Inc. | Private Equity Investor | ||
PhRMA Foundation
PhRMA Foundation Miscellaneous Commercial ServicesCommercial Services The PhRMA Foundation is an organization that provides awards and support to individuals pursuing higher education. The non-profit company is based in Washington. The organization's 2022 annual report highlights their activities and showcases their 2022 awardees. | Miscellaneous Commercial Services | Chairman | |
SRI Consulting, Inc.
SRI Consulting, Inc. Miscellaneous Commercial ServicesCommercial Services SRI Consulting, Inc. provides information technology and business support services. It specializes in the development, implementation and maintenance of software solutions. The company was founded by Philip C. Sharpe in 1995 and is headquartered in Fairfax, VA. | Miscellaneous Commercial Services | Consultant / Advisor | |
VOYAGER THERAPEUTICS, INC. | Biotechnology | Chief Executive Officer | |
Padlock Therapeutics, Inc.
Padlock Therapeutics, Inc. BiotechnologyHealth Technology Padlock Therapeutics, Inc. develops medicines targeting protein-arginine deiminases. It develops drugs that block the protein-arginine deiminase (PAD) enzymes. The firm leverages the breakthrough science on the role of protein citrullination in disease to develop drugs targeting protein-arginine deiminase (PAD) enzymes. The company was founded by Paul Thompson, Kerri Mowen, Todd A. Huffman and Michael Gilman in January 2014 and is headquartered in Cambridge, MA. | Biotechnology | Chief Tech/Sci/R&D Officer | |
Verge Analytics, Inc.
Verge Analytics, Inc. BiotechnologyHealth Technology Verge Analytics, Inc. engages in the provision of biotechnology services. It develops drugs for neurodegenerative diseases using computational genomics. The company was founded by Alice Zhang and Jason Chen in 2015 and is headquartered in San Francisco, CA. | Biotechnology | Director/Board Member | |
PierianDx, Inc.
PierianDx, Inc. Information Technology ServicesTechnology Services PierianDx, Inc. provides genomic software and services. It develops a platform to manage, analyze, and interpret complex genomic tests for clinical laboratories across the United States. The firm?s genomics software platform, Clinical Genomicist Workstation (CGW), provides data-driven workflow for health systems, academic medical centers, and commercial labs to improve patient outcomes through genomic analysis, interpretation and reporting. The company was founded by Jeffrey D. Milbrandt, Karen Seibert, John D. Pfeifer, Herbert W. Virgin, and Rakesh Nagarajan in 2014 and is headquartered in St. Louis, MO. | Information Technology Services | Founder | |
Indalo Therapeutics, Inc.
Indalo Therapeutics, Inc. BiotechnologyHealth Technology Indalo Therapeutics, Inc. operates as a biopharmaceutical firm that develops integrin antagonists for patients suffering from serious fibrotic diseases such as nonalcoholic steatohepatitis (NASH) and idiopathic pulmonary fibrosis (IPF). The company was founded by David Griggs, Williamson Z. Bradford III, Peter Ruminski, and Robert W. Karr and is headquartered in Cambridge, MA. | Biotechnology | Director/Board Member | |
PRAXIS PRECISION MEDICINES, INC. | Pharmaceuticals: Major | Director/Board Member | |
Biogen-Idec Pharmaceuticals, Inc.
Biogen-Idec Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Part of Spectrum Pharmaceuticals, Inc., Biogen-Idec Pharmaceuticals, Inc. manufactures pharmaceutical products. The company is based in Gaithersburg, MD. | Pharmaceuticals: Major | Private Equity Investor | |
DECIPHERA PHARMACEUTICALS, INC. | Biotechnology | Consultant / Advisor | |
Pfizer, Inc. /India/ | Director/Board Member | ||
Atalanta Therapeutics, Inc.
Atalanta Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Atalanta Therapeutics, Inc. develops RNA interference based therapeutics to treat neurodegenerative diseases. The company is based in Boston, MA. The company was founded by Neil Aronin, Craig C. Mello, Anastasia Khvorova, Jim Glasheen. The CEO is Alicia Secor. | Miscellaneous Commercial Services | Director/Board Member | |
Rectify Pharmaceuticals LLC
Rectify Pharmaceuticals LLC Miscellaneous Commercial ServicesCommercial Services Rectify Pharmaceuticals LLC is a biotech company that is developing positive functional modulators (PFMs) to address the underlying cause of serious ABC transporter-mediated diseases. The company is based in Cambridge, MA and was founded by Jonathan Moore. The company's team includes Xiaobing Li as Chief Development Officer, Robert Hughes as Executive Vice President of Drug Discovery and Preclinical Development, and Leif-Ann Tuohey as Senior Vice President and Head of Business Development. The company has received $100 million in Series A financing from Atlas Venture, Omega Funds, Forbion, and Longwood Fund. The CEO is Rajesh Devraj, who is also a venture partner at Atlas Venture. | Miscellaneous Commercial Services | Chief Executive Officer | |
Endlyz Therapeutics, Inc.
Endlyz Therapeutics, Inc. BiotechnologyHealth Technology Endlyz Therapeutics, Inc. is an American company that operates in the biotechnology industry. | Biotechnology | Director/Board Member | |
Transition Bio, Inc.
Transition Bio, Inc. BiotechnologyHealth Technology Transition Bio, Inc. is a company based in Watertown, MA that is developing technologies for biomolecular condensate analysis. The company's proprietary drug discovery platform, CondensomicsTM, utilizes droplet microfluidics and machine learning to map and modulate condensates in molecular detail. The company's goal is to build a drug discovery engine based on the latest advancements in biophysics and artificial intelligence. Transition Bio has been founded by Sarah Teichmann, David A. Weitz, Peter H. St George-Hyslop, and Tuomas Knowles. | Biotechnology | Director/Board Member | |
AbbVie Ventures LLC
AbbVie Ventures LLC Investment ManagersFinance AbbVie Ventures LLC (AbbVie Ventures) is a venture capital firm, a subsidiary of AbbVie, Inc. founded in 2009. The firm is headquartered in North Chicago, Illinois. | Investment Managers | Private Equity Investor |
Statistiche
Distribuzione geografica
Stati Uniti | 47 |
India | 3 |
Regno Unito | 2 |
Israele | 2 |
Settori
Health Technology | 26 |
Consumer Services | 8 |
Finance | 7 |
Commercial Services | 7 |
Miscellaneous | 2 |
Posizioni
Director/Board Member | 46 |
Corporate Officer/Principal | 15 |
Private Equity Investor | 11 |
Consultant / Advisor | 9 |
Independent Dir/Board Member | 8 |
Contatti più connessi
Insiders | |
---|---|
Jean George | 33 |
Alfred Sandrock | 16 |
Rajesh Devraj | 12 |
John Gustofson | 12 |
Kimi Iguchi | 10 |
Raul Krauss | 6 |
Tom Engber | 6 |
Jeffrey D Milbrandt | 2 |
- Borsa valori
- Insiders
- Thomas Engber
- Connessioni Società